Dr. Robert Marion is retired from Novartis where he worked was Director, Technical Project Leader in Technical Research and Development. He directed product development activities from late stage research through drug approvals including chemical and pharmaceutical development, production of clinical trial materials, quality control, and regulatory submissions. He developed to market over 20 products in ophthalmic, neuroscience and oncology therapeutic areas. He was also the director of analytical laboratories. Prior to Novartis he worked at G.D. Searle in quality technical services. He holds a B.S. Pharm. from University of Mississippi and Ph.D in Pharmaceutical Sciences from Mercer University.